Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Growth Metrics
Income Statement
Others
Ratios

Stemtech (STEK) Change in Receivables (2020 - 2025)

Stemtech's Change in Receivables history spans 6 years, with the latest figure at -$20958.0 for Q3 2025.

  • For Q3 2025, Change in Receivables changed N/A year-over-year to -$20958.0; the TTM value through Sep 2025 reached $95912.0, down 25.03%, while the annual FY2024 figure was $208255.0, 679.19% up from the prior year.
  • Change in Receivables for Q3 2025 was -$20958.0 at Stemtech, down from $87138.0 in the prior quarter.
  • Across five years, Change in Receivables topped out at $119208.0 in Q1 2021 and bottomed at -$132528.0 in Q2 2021.
  • The 5-year median for Change in Receivables is $6676.0 (2022), against an average of $16703.6.
  • The largest annual shift saw Change in Receivables skyrocketed 4384.7% in 2022 before it tumbled 725.21% in 2023.
  • A 5-year view of Change in Receivables shows it stood at -$1416.0 in 2021, then tumbled by 252.19% to -$4987.0 in 2022, then crashed by 725.21% to -$41153.0 in 2023, then soared by 195.19% to $39174.0 in 2024, then crashed by 153.5% to -$20958.0 in 2025.
  • Per Business Quant, the three most recent readings for STEK's Change in Receivables are -$20958.0 (Q3 2025), $87138.0 (Q2 2025), and -$9442.0 (Q1 2025).